The bill H.209, introduced by Representative Goldman, aims to enhance the management of life-threatening allergies in schools by allowing health care professionals to prescribe and issue standing orders for intranasal epinephrine, in addition to epinephrine auto-injectors. It permits schools to maintain a stock supply of both intranasal epinephrine and auto-injectors, and authorizes school administrators to designate school nurses or other personnel to administer or allow students to self-administer these medications according to individualized action plans. The bill includes provisions for training designated personnel and establishes protocols for responding to allergic reactions.

Key amendments to current law include the insertion of definitions for "intranasal epinephrine" and the ability for health care professionals to prescribe both intranasal epinephrine and auto-injectors. The bill also clarifies that designated personnel and schools will be immune from civil or criminal liability when administering these medications, provided their actions do not constitute intentional misconduct. The act is set to take effect on July 1, 2025.

Statutes affected:
As Introduced: 16-1388